Intra Cellular Therapies | 当期純利益



Net Income 変化する 日付
Acadia Pharmaceuticals USD 18.99M 124.76M 2025-03
ALKERMES USD 22.46M 344.61M 2025-03
Biogen USD 240.5M 26.2M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Cytokinetics USD -161376000 11.36M 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
Halozyme Therapeutics USD 118.1M 18.92M 2025-03
J&J USD 11B 7.57B 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
Prothena USD -57956000 1.04M 2024-12
RedHill Biopharma USD -1540000 0 2024-06
Supernus Pharmaceuticals USD 15.33M 23.17M 2024-12
United Therapeutics USD 322.2M 20.9M 2025-03



Intra Cellular Therapies 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - May 2025.